ProfileGDS4718 / 213309_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 90% 94% 71% 94% 93% 60% 61% 91% 95% 93% 89% 93% 87% 43% 74% 83% 91% 63% 78% 73% 90% 92% 94% 90% 88% 71% 92% 49% 93% 63% 84% 60% 95% 91% 67% 66% 81% 90% 95% 76% 93% 52% 74% 58% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.1947590
GSM549102patient 115, normal, homogenized [OPG study]9.9789694
GSM549104patient 119, normal, homogenized [OPG study]6.9841771
GSM549108patient 138, normal, homogenized [OPG study]9.9370394
GSM549119patient 077, normal, homogenized [OPG study]9.8241893
GSM549133patient 032, cancer, homogenized [OPG study]6.0983360
GSM549139patient 042, cancer, homogenized [OPG study]6.1938761
GSM549099patient 107, normal, homogenized [OPG study]9.2710191
GSM549109patient 139, normal, homogenized [OPG study]10.411795
GSM549110patient 046, normal, homogenized [OPG study]9.8524593
GSM549114patient 063, normal, homogenized [OPG study]9.1320389
GSM549122patient 082, normal, homogenized [OPG study]9.8384193
GSM549134patient 033, cancer, homogenized [OPG study]8.7595687
GSM549136patient 036, cancer, homogenized [OPG study]5.0593543
GSM549140patient 044, cancer, homogenized [OPG study]7.3466174
GSM549111patient 047, normal, homogenized [OPG study]8.3016683
GSM549113patient 057, normal, homogenized [OPG study]9.6344891
GSM549132patient 031, cancer, homogenized [OPG study]6.3071263
GSM549137patient 038, cancer, homogenized [OPG study]7.6278978
GSM549142patient 047, cancer, homogenized [OPG study]7.043473
GSM549100patient 110, normal, homogenized [OPG study]9.2448690
GSM549107patient 135, normal, homogenized [OPG study]9.5823192
GSM549115patient 068, normal, homogenized [OPG study]10.245594
GSM549116patient 072, normal, homogenized [OPG study]9.2827490
GSM549120patient 078, normal, homogenized [OPG study]8.8353388
GSM549131patient 030, cancer, homogenized [OPG study]7.0809171
GSM549118patient 074, normal, homogenized [OPG study]9.5220292
GSM549129patient 027, cancer, homogenized [OPG study]5.460749
GSM549123patient 088, normal, homogenized [OPG study]9.9357193
GSM549124patient 006, cancer, homogenized [OPG study]6.3502163
GSM549126patient 015, cancer, homogenized [OPG study]8.3380584
GSM549128patient 025, cancer, homogenized [OPG study]6.1391460
GSM549103patient 117, normal, homogenized [OPG study]10.334595
GSM549117patient 073, normal, homogenized [OPG study]9.6237491
GSM549138patient 041, cancer, homogenized [OPG study]6.6508267
GSM549141patient 045, cancer, homogenized [OPG study]6.5901866
GSM549130patient 028, cancer, homogenized [OPG study]7.9143381
GSM549101patient 111, normal, homogenized [OPG study]9.0750890
GSM549105patient 128, normal, homogenized [OPG study]10.193995
GSM549106patient 134, normal, homogenized [OPG study]7.5598876
GSM549112patient 048, normal, homogenized [OPG study]9.9257393
GSM549125patient 011, cancer, homogenized [OPG study]5.6131852
GSM549127patient 024, cancer, homogenized [OPG study]7.3399774
GSM549135patient 035, cancer, homogenized [OPG study]5.9843458